Skip to content
10-Q

Quarterly Report

21st Century Oncology Holdings, Inc.

0001104659-16-145688

← back to feed
Filed
Sep 20, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Sep 20, 2016 1.06K sh
Capex Q1 2016 · Mar 31, 2016 $12.26M
Capex restated Q1 2016 · Mar 31, 2015 $12.2M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $72.4M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $65.21M
Cash And Equivalents restated Q1 2016 · Mar 31, 2015 $77.97M
Cash And Equivalents restated Q1 2016 · Dec 31, 2014 $99.08M
Stockholders Equity Q1 2016 · Mar 31, 2016 −$723M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$700.95M
Current Liabilities Q1 2016 · Mar 31, 2016 $1.27B
Current Liabilities Q1 2016 · Dec 31, 2015 $1.21B
Total Liabilities Q1 2016 · Mar 31, 2016 $1.41B
Total Liabilities Q1 2016 · Dec 31, 2015 $1.37B
Current Assets Q1 2016 · Mar 31, 2016 $251.61M
Current Assets Q1 2016 · Dec 31, 2015 $221.28M
Total Assets Q1 2016 · Mar 31, 2016 $1.15B
Total Assets Q1 2016 · Dec 31, 2015 $1.1B
Sga Expense Q1 2016 · Mar 31, 2016 $29.37M
Sga Expense restated Q1 2016 · Mar 31, 2015 $28.97M
Net Income Q1 2016 · Mar 31, 2016 $825K
Net Income Q1 2016 · Mar 31, 2015 −$16.67M
Gross Profit Q1 2016 · Mar 31, 2016 $77.55M
Gross Profit restated Q1 2016 · Mar 31, 2015 $80.06M
Cost Of Revenue Q1 2016 · Mar 31, 2016 $197.4M
Cost Of Revenue restated Q1 2016 · Mar 31, 2015 $201.2M